JCI - Citations to Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.

Citations to this article

Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.

K A Foon, … , H Köhler, M Bhattacharya-Chatterjee

K A Foon, … , H Köhler, M Bhattacharya-Chatterjee

Published July 1, 1995
Citation Information: J Clin Invest. 1995;96(1):334-342. https://doi.org/10.1172/JCI118039.

View: Text | PDF

Research Article

Total citations by year

Year:	2022	2020	2019	2018	2016	2015	2012	2011	2009	2008	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1976	Total
Citations:	1	1	2	1	2	1	3	2	4	1	4	13	3	6	7	8	6	9	7	4	1	1	87

Citation information

Citations to this article (87)

Title and authors	Publication	Year
Exploring immunotherapy in colorectal cancer Weng J, Li S, Zhu Z, Liu Q, Zhang R, Yang Y, Li X	Journal of Hematology & Oncology	2022
Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases SY Pan, YC Chia, HR Yee, AY Cheng, CE Anjum, Y Kenisi, MK Chan, MB Wong	Future Science OA	2020
scFv6.C4 DNA vaccine with fragment C of Tetanus toxin increases protective immunity against CEA-expressing tumor BF Zanetti, CP Ferreira, JR de Vasconcelos, SW Han	Gene Therapy	2019
The Promise of Anti-idiotype Revisited H Kohler, A Pashov, T Kieber-Emmons	Frontiers in immunology	2019
Recapitulation of the anti-Idiotype antibodies as vaccine candidate A Naveed, SU Rahman, MI Arshad, B Aslam	Translational Medicine Communications	2018
Preventive DNA vaccination against CEA-expressing tumors with anti-idiotypic scFv6.C4 DNA in CEA-expressing transgenic mice PM Denapoli, BF Zanetti, AA Santos, JZ de Moraes, SW Han	Cancer Immunology, Immunotherapy	2016
Preventive DNA vaccination against CEA-expressing tumors with anti-idiotypic scFv6.C4 DNA in CEA-expressing transgenic mice. Denapoli PMA, Zanetti BF, Dos Santos AA, de Moraes JZ, Han SW	Cancer Immunology, Immunotherapy	2016
Induction of protective and therapeutic anti-cancer immunity by using bispecific anti-idiotype antibody G22-I50 for nasopharyngeal carcinoma JJ Wang, YH Liu, GC Li	International Immunopharmacology	2015
Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications JS Testa, R Philip	Future Virology	2012
Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data AM Vázquez, AM Hernández, A Macías, E Montero, DE Gómez, DF Alonso, MR Gabri, RE Gómez	Frontiers in Oncology	2012
Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements MZ Ladjemi	Frontiers in Oncology	2012
Encyclopedia of Life Sciences B Dahlbäck	Encyclopedia of Life Sciences	2011
Expression, characterization and therapeutic efficacy of chimeric Fab of anti-idiotypic antibody NP30 against Schistosoma japonicum J Xu, XJ Zhu, YH Li, Y Dai, YC Zhu, J Zheng, ZQ Feng, XH Guan	Acta Tropica	2011
Monoclonal antibodies for cancer immunotherapy LM Weiner, MV Dhodapkar, S Ferrone	Lancet	2009
Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy J Liu, L Gunn, R Hansen, J Yan	Experimental and Molecular Pathology	2009
Anti-idiotypic antibodies: a new approach in prion research AC Venturini, M Bresjanac, T Vranac, S Koren, M Narat, M Popović, VC Serbec	BMC Immunology	2009
Principles of Cancer Biotherapy RK Oldham, RO Dillman		2009
Carcinoembryonic antigen as a vaccine target D Wang, S Rayani, JL Marshall	Expert Review of Vaccines	2008
Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen A Saha, SK Chatterjee, KA Foon, M Bhattacharya-Chatterjee	Immunology	2006
Development of the PANVAC™-VF vaccine for pancreatic cancer CA Petrulio, HL Kaufman	Expert Review of Vaccines	2006
A Randomized Phase II Study of Docetaxel Alone or in Combination with PANVAC™-V (Vaccinia) and PANVAC™-F (Fowlpox) in Patients with Metastatic Breast Cancer (NCI 05-C-0229) PM Arlen, M Pazdur, L Skarupa, M Rauckhorst, JL Gulley	Clinical Breast Cancer	2006
Colorectal Cancer G Chong, D Cunningham	Colorectal Cancer	2006
Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study AP Zbar, H Thomas, RW Wilkinson, M Wadhwa, KN Syrigos, EL Ross, P Dilger, TG Allen-Mersh, WA Kmiot, AA Epenetos, D Snary, WF Bodmer	International Journal of Colorectal Disease	2005
Colorectal cancer vaccines: What we know and what we don’t yet know M Mehren	Seminars in Oncology	2005
CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice A Saha, RN Baral, SK Chatterjee, K Mohanty, S Pal, KA Foon, FJ Primus, AM Krieg, GJ Weiner, M Bhattacharya-Chatterjee	Cancer Immunology, Immunotherapy	2005
Graft-versus-Tumor Effect Against Advanced Pancreatic Cancer after Allogeneic Reduced-Intensity Stem Cell Transplantation Y Kanda, Y Komatsu, M Akahane, S Kojima, Y Asano-Mori, M Tada, K Oshima, H Isayama, S Ogawa, T Motokura, S Chiba, K Ohtomo, M Omata, H Hirai	Transplantation	2005
Yeast whole glucan particle (WGP) β-glucan in conjunction with antitumour monoclonal antibodies to treat cancer J Yan, DJ Allendorf, B Brandley	Expert Opinion on Biological Therapy	2005
Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine R Baral, I Mandal, U Chattopadhyay	International Immunopharmacology	2005
Measuring Immunity MT Stang, JH Yim	Measuring Immunity	2005
Immunologic Therapies for Gastrointestinal Cancers B Levy, JF Deeken, G Holt, JL Marshall	Clinical Colorectal Cancer	2005
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer MJ Goldstein, EP Mitchell	Cancer Investigation	2005
Tumor Immunology and Cancer Vaccines SN Khleif		2005
Drugs Affecting Growth of Tumours HM Pinedo, CH Smorenburg		2005
Differential Immunogenicity of Two Peptides Isolated by High Molecular Weight-Melanoma-Associated Antigen-Specific Monoclonal Antibodies with Different Affinities W Luo, JC Hsu, CY Tsao, E Ko, X Wang, S Ferrone	Journal of immunology (Baltimore, Md. : 1950)	2005
CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice. Saha A, Baral RN, Chatterjee SK, Mohanty K, Pal S, Foon KA, Primus FJ, Krieg AM, Weiner GJ, Bhattacharya-Chatterjee M	Cancer Immunology, Immunotherapy	2005
A novel CEA vaccine stimulates T cell proliferation, γIFN secretion and CEA specific CTL responses T Parsons, I Spendlove, R Nirula, M Writer, G Carter, F Carr, LG Durrant	Vaccine	2004
Handbook of Cancer Vaccines MA Morse, TM Clay, HK Lyerly		2004
Vaccination of Patients with Advanced Ovarian Carcinoma with the Anti-Idiotype ACA125: Immunological Response and Survival (Phase Ib/II) S Reinartz, S Köhler, H Schlebusch, K Krista, P Giffels, K Renke, J Huober, V Möbus, R Kreienberg, A duBois, P Sabbatini, U Wagner	Clinical cancer research	2004
Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients B Birebent, E Mitchell, N Akis, W Li, R Somasundaram, E Purev, D Hoey, M Mastrangelo, H Maguire, DT Harris, S Nair, D Cai, T Zhang, DM Herlyn	Vaccine	2003
Prospects for colorectal cancer treatment: oral chemotherapy and targeted biotherapy J Bennouna, JY Douillard	Expert Review of Anticancer Therapy	2003
Cancer Chemotherapy and Biological Response Modifiers Annual MS Turner, JR McKolanis, RK Ramanathan, DC Whitcomb, OJ Finn	Cancer Chemotherapy and Biological Response Modifiers Annual Volume 21	2003
Principles of cancer treatment by immunotherapy LG Durrant, JH Scholefield	Surgery (Oxford)	2003
Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system LH Lund, K Andersson, B Zuber, A Karlsson, G Engström, J Hinkula, B Wahren, G Winberg	Cancer Gene Therapy	2003
Negative CEA values in Metastatic Colorectal Carcinoma and the Likelihood of Complete Chemotherapy Response Z Tomasevic, S Jelic, L Nikolic, I Filipovic, L Stamatovic, D Radosavljevic	The International Journal of Biological Markers	2003
Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer C Maxwell-Armstrong	Annals of the Royal College of Surgeons of England	2002
Anti-idiotype antibody vaccine therapy for cancer M Bhattacharya-Chatterjee, SK Chatterjee, KA Foon	Expert Opinion on Biological Therapy	2002
Immunotherapy for pancreatic cancer: current concepts HL Kaufman, JD Vito, H Hörig	Hematology/Oncology Clinics of North America	2002
Gene Therapy of Cancer IV Lebedeva, CA Stein	Gene Therapy of Cancer	2002
Functional mimicry of an anti-idiotypic antibody to nominal antigen on cellular response Jie Ma, Liqiang Zhou, Daqing Wang	Japanese journal of cancer research : Gann	2002
Immunotherapy of colorectal cancer CL Smith, N Dulphy, M Salio, V Cerundolo	British Medical Bulletin	2002
Functional Mimicry of an Anti‐idiotypic Antibody to Nominal Antigen on Cellular Response Ma J, Zhou L, Wang D	Japanese journal of cancer research : Gann	2002
Strategies for Mimicking Neisserial Saccharide Epitopes as Vaccines S Gulati, J Ngampasutadol, R Yamasaki, DP McQuillen, PA Rice	International Reviews of Immunology	2001
Immunotherapy for colorectal cancer KA Foon	Current Oncology Reports	2001
Interim Analysis of the Use of the Anti-Idiotype Breast Cancer Vaccine 11D10 (TriAb®) in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer DE Reece, KA Foon, M Battacharya-Chatterjee, D Adkins, ER Broun, DG Connaghan, JF Dipersio, HK Holland, DS Howard, GA Hale, HG Klingemann, RK Munn, A Raptis, GL Phillips	Clinical Breast Cancer	2001
The impact of immune responses on lung cancer and the development of new treatment modalities E Pluygers, A Sadowska, L Chyczewski, J Nikliński, W Niklińska, E Chyczewska	Lung Cancer	2001
Cancer immunotherapy: insights from transgenic animal models PM McLaughlin, BJ Kroesen, MC Harmsen, LF de Leij	Critical Reviews in Oncology/Hematology	2001
INNOVATIVE TREATMENTS FOR PANCREATIC CANCER SM Lieberman, H Hörig, HL Kaufman	Surgical Clinics of North America	2001
Brain Tumor Immunotherapy LM Liau, DP Becker, TF Cloughesy, DD Bigner		2001
CancerVax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon Cancer N Habal, RK Gupta, AJ Bilchik, R Yee, Z Leopoldo, W Ye, RM Elashoff, DL Morton	Annals of Surgical Oncology	2001
Anti-idiotype vaccine against cancer M Bhattacharya-Chatterjee, SK Chatterjee, KA Foon	Immunology Letters	2000
Biological Therapy of Breast Cancer JW Park, D Tripathy, MJ Campbell, LJ Esserman	BioDrugs	2000
Cancer and Autoimmunity O Pritsch, G Dighiero	Cancer and Autoimmunity	2000
Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer DE Reece, KA Foon, M Bhattacharya-Chatterjee, GA Hale, DS Howard, RK Munn, R Nath, BA Plummer, A Teitelbaum, GL Phillips	Bone Marrow Transplantation	2000
Clinical and Immune Responses in Advanced Melanoma Patients Immunized With an Anti-Idiotype Antibody Mimicking Disialoganglioside GD2 KA Foon, J Lutzky, RN Baral, JR Yannelli, L Hutchins, A Teitelbaum, OL Kashala, R Das, J Garrison, RA Reisfeld, M Bhattacharya-Chatterjee	Journal of Clinical Oncology	2000
Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide E Salazar, S Zaremba, PM Arlen, KY Tsang, J Schlom	International Journal of Cancer	2000
Construction and Characterization of a Chimeric Fusion Protein Consisting of an Anti-idiotype Antibody Mimicking a Breast Cancer-Associated Antigen and the Cytokine GM-CSF PK Tripathi, H Qin, M Bhattacharya-Chatterjee, RL Ceriani, KA Foon, SK Chatterjee	Hybridoma	1999
Milestones in the Development of Lym-1 Therapy GE DeNARDO, RT O'donnell, LM Rose, GR Mirick, LA Kroger, SA DeNARDO	Hybridoma	1999
Evaluation of Immunological Responses in Patients with Ovarian Cancer Treated with the Anti-idiotype Vaccine ACA125 by Determination of Intracellular Cytokines—A Preliminary Report S Reinartz, H Boerner, S Koehler, AV Ruecker, H Schlebusch, U Wagner	Hybridoma	1999
Immunotherapy for colorectal cancer CA Maxwell-Armstrong, LG Durrant, JH Scholefield	The American Journal of Surgery	1999
IMMUNOGLOBULIN VARIABLE REGIONS AS IDIOTYPE VACCINES PS Hefty, RC Kennedy	Infectious Disease Clinics of North America	1999
Clinical and Immune Responses in Resected Colon Cancer Patients Treated With Anti-Idiotype Monoclonal Antibody Vaccine That Mimics the Carcinoembryonic Antigen KA Foon, WJ John, M Chakraborty, R Das, A Teitelbaum, J Garrison, O Kashala, SK Chatterjee, M Bhattacharya-Chatterjee	Journal of Clinical Oncology	1999
Phase I Study in Cancer Patients of a Replication-Defective Avipox Recombinant Vaccine That Expresses Human Carcinoembryonic Antigen JL Marshall, MJ Hawkins, KY Tsang, E Richmond, JE Pedicano, MZ Zhu, J Schlom	Journal of Clinical Oncology	1999
Educational Review Cellular and Biological Therapies of Gastrointestinal Tumors: Overview of Clinical Trials MA Morse, HK Lyerly	Annals of Surgical Oncology	1999
Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte I Nukaya, M Yasumoto, T Iwasaki, M Ideno, A Sette, E Celis, K Takesako, I Kato	International Journal of Cancer	1999
Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide D Lou, H Kohler	Nature Biotechnology	1998
Idiotype vaccines in the clinic KA Foon, M Bhattarcharya-Chatterjee	Nature Medicine	1998
Antigen mimicry by an anti-idiotypic antibody single chain variable fragment PK Tripathi, H Qin, S Deng, C Xu, M Bhattacharya-Chatterjee, KA Foon, SK Chatterjee	Molecular Immunology	1998
Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs LJ Hefta, M Neumaier, JE Shively	Immunotechnology	1998
Marqueurs tumoraux et vaccins anti cancer, une voie difficile M Ferrero-Pous	Immuno-analyse & Biologie Spécialisée	1998
Colorectal cancer vaccines Maxwell-Armstrong, Durrant, Scholefield	The British journal of surgery	1998
Biological and Hormonal Therapies of Cancer KA Foon, HB Muss		1998
Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses JW Hodge, JP McLaughlin, JA Kantor, J Schlom	Vaccine	1997
Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: An animal model for CEA-directed tumor immunotherapy JA Thompson, AM Eades-Perner, M Ditter, WJ Muller, W Zimmermann	International Journal of Cancer	1997
Low Doses of 105AD7 Cancer Vaccine Preferentially Stimulate Anti-Tumor T-Cell Immunity L Durrant, D Buckley, I Spendlove, R Robins	Hybridoma	1997
Idiotypes in Medicine: Autoimmunity, Infection and Cancer TJ Kunicki, DJ Nugent	Idiotypes in Medicine: Autoimmunity, Infection and Cancer	1997
1975–1995 Revised anti-cancer serological response: Biological significance and clinical implications S Canevari, SM Pupa, S Ménard	Annals of Oncology	1996
Immunology for Surgeons JE Castro		1976

Advertisement